BRUS, MICHAEL J. MD; SOLANTO, MARY V. PhD; GOLDBERG, JOSEPH F. MD
BRUS: Icahn School of Medicine at Mt. Sinai, New York, NY; SOLANTO: New York University School of Medicine, New York, NY; GOLDBERG: Icahn School of Medicine at Mt. Sinai and Silver Hill Hospital, New Canaan, CT
Joseph Goldberg: Scientific Advisory Board: Avanir Pharmaceuticals, Mylan Pharmaceuticals. Consultant: Medical Communications, MedScape, WebMD. Speakers’ Bureau: Astra Zeneca, Merck, Mylan Pharmaceuticals, Novartis, Sunovion, Takeda. Royalties: American Psychiatric Publishing, Inc. The other authors declare no conflicts of interest.
Please send correspondence to: Michael J. Brus, MD, Icahn School of Medicine at Mt. Sinai, 16 East 96th St., Suite 1A, New York, NY 10128. [email protected]